Innovation Gateway added additional fields of use to an existing agreement with Life Technologies Corporation surrounding click chemistry applications.
Innovation Gateway hosted two Lunch and Learn sessions. Ted Keim and Kat McDavitt of Dodge Communications provided information on preparing and disseminating press releases, and Joe Cornicelli of Charles River Laboratories highlighted a drug discovery case study that led to a breakthrough treatment for cancer.
A member of the Innovation Gateway team moderated a panel at the Eastern Regional Meeting of the Association of University Technology Managers which included product development directors from ThermoFisher, Kerafast and MilliporeSigma (Merck), discussing licensing and commercialization strategies for research tools and reagents.
Five agreements were signed permitting evaluations of the experimental bermudagrass and zoysiagrass lines developed by Brian Schwartz, crop and soil sciences department.
Steve Stice, CSO of ArunA Biomedical, joined the Georgia Research Alliance Board of Trustees.
Two agreements were signed allowing evaluation of the experimental tall fescue and annual ryegrass lines developed by Ali Missaoui, crop and soil sciences department.
Innovation Gateway exclusively licensed the PIV5 vaccine platform technology developed by Biao He, department of infectious diseases, to a start-up company for a limited field of use.
Steve Stice of ArunA Biomedical, Kausar Samli of Lectenz Bio, and Felipe Sarmiento of Swissaustral participated in an Athens-Clarke County Economic Development Bioscience Panel.
Innovation Gateway hosted a visit by Mayor Seok-jin Mun of Seodaemun, Seoul, South Korea, sharing ideas and practices to spur university-launched ventures.
Glycoscientific, a UGA startup company, received a $242,306 STTR grant to utilize a newly developed methodology enabling reliable production of antibodies able to recognize distinct protein epitopes in the context of specific glycan modifications.